PharmaCielo Makes Leap Across The Pond With 2 Large-Scale CBD, THC Extracts Sales Agreements

Benzinga.com, Javier Hasse, January 28, 2020

Canadian-Colombian medical cannabis company PharmaCielo Ltd (TSXV:PCLO) PCLOF 6.57% is taking a leap across the pond after securing a string of sales and distribution agreements for its medicinal-grade CBD and THC extracts in the European market.

Earlier this week, the company announced a significant sales agreement with XPhyto Therapeutics Corp. (CSE:XPHY), its largest to date.

Per the three-year agreement, PharmaCielo will supply a minimum of 30,000 Kg of medicinal-quality cannabis oils and isolates, including those containing THC, to XPhyto’s EU-GMP certified facility in Germany for further processing and usage in medical cannabis products for the German market. …

This agreement comes on the heels of another distribution deal PharmaCielo signed with CBD Export Global for the distribution of CBD isolates and broad-spectrum CBD oils to European wholesalers and CPG product manufacturers. …

Read more.